Main > A1. CORP. INDEX. Bn-Bz > BridgeBio Pharma. C2

---

2017. 01.03 - Patents: YES

BridgeBio Pharma. C2's subsections
2017. 01.03. Launch Date
2017. 04.27. Eidos Therapeutics
2017. 10.04. Navire Pharma
2018. 01.30. QED Therapeutics
2019. 09.05. ML Bio Solutions
2020. 10.05. Eidos Therapeutics
2021. 02.28. MoCD>Fosdenopterin>USA
2021. 10.29. Collaborations
2022. 05.12. BMS License Agreement
2022. 09.20. MoCD>Fosdenopterin>EU>
2024. 08.22. GondolaBio
Eidos Therapeutics Inc./P C2
web-site

BridgeBio Pharma. C2's products
This section has no products